(Q39968605)

16 September 2017

title

Considerations for intravascular administration of oncolytic herpes virus for the treatment of multiple liver metastases (English)

1 reference

16 September 2017

1 reference

Naohiro Nomura

1

1 reference

16 September 2017

Hideki Kasuya

2

1 reference

16 September 2017

Izuru Watanabe

3

1 reference

16 September 2017

Toshio Shikano

4

1 reference

16 September 2017

Takashi Shirota

5

1 reference

16 September 2017

Makoto Misawa

6

1 reference

16 September 2017

Hiroyuki Sugimoto

7

1 reference

16 September 2017

Naohito Kanazumi

8

1 reference

16 September 2017

Shuji Nomoto

9

1 reference

16 September 2017

Shin Takeda

10

1 reference

16 September 2017

Akimasa Nakao

11

1 reference

16 September 2017

publication date

25 June 2008

1 reference

Cancer Chemotherapy and Pharmacology

16 September 2017

published in

1 reference

16 September 2017

volume

63

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

321-330

1 reference

Infections with herpes simplex viruses (1).

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-008-0742-6

Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-008-0742-6

Inhibition of rat vascular smooth muscle cell proliferation in vitro and in vivo by recombinant replication-competent herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-008-0742-6

Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-008-0742-6

10.1007/S00280-008-0742-6

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference